Natural Product: NPC169485
Natural Product ID:   | NPC169485 |
Common Name*:   | [(1S,5R)-8-Methyl-8-Azabicyclo[3.2.1]Octan-3-Yl] (2R)-3-Hydroxy-2-Phenylpropanoate |
IUPAC Name:   | [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-3-hydroxy-2-phenylpropanoate |
Synonyms:   | |
Standard InCHIKey:   | RKUNBYITZUJHSG-QXULXFAOSA-N |
Standard InCHI:   | InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/p+1/t13-,14+,15?,16-/m0/s1 |
SMILES:   | C[NH+]1[C@H]2CC[C@@H]1CC(C2)OC(=O)[C@@H](CO)c1ccccc1
|
Synthetic Gene Cluster:   |
n.a. |
ChEMBL Identifier:   |
CHEMBL1379091 |
PubChem CID:   |
637577 |
Chemical Classification**:   |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0000279] Alkaloids and derivatives
-
[CHEMONTID:0000492] Tropane alkaloids
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
Seeds |
n.a. |
|
DOI[10.1002/ejlt.201100207] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
DOI[10.1007/s11746-997-0093-1] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
Seeds |
n.a. |
|
DOI[10.5219/332] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
seeds |
n.a. |
n.a. |
PMID[11858758] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
fruits |
n.a. |
n.a. |
PMID[12467621] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[15374592] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
root |
n.a. |
PMID[16212233] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
flowers |
Yuxi Town, Fuqing City, Fujian Province, China |
2005-SEP |
PMID[17583953] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[22537213] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
root bark |
n.a. |
n.a. |
PMID[23282106] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[24417583] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
Seeds |
n.a. |
n.a. |
PMID[26923696] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
Root Bark |
n.a. |
n.a. |
PMID[26982999] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[31397570] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
fruits |
n.a. |
n.a. |
PMID[9090870] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
|
Database[FooDB] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
|
n.a. |
n.a. |
Database[FooDB] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
Seed |
n.a. |
n.a. |
Database[FooDB] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
Seed Oil |
n.a. |
n.a. |
Database[FooDB] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO3890 |
Scopolia japonica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO25993 |
Atropa belladonna |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO10384 |
Scopolia carniolica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO10384 |
Scopolia carniolica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO25993 |
Atropa belladonna |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO3890 |
Scopolia japonica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO25993 |
Atropa belladonna |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO3890 |
Scopolia japonica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO3890 |
Scopolia japonica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO10384 |
Scopolia carniolica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO25993 |
Atropa belladonna |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO16326 |
Scopolia parviflora |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO17823 |
Lycium chinense |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO3890 |
Scopolia japonica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO23429 |
Lycium barbarum |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO6495 |
Datura stramonium |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO25993 |
Atropa belladonna |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO16326 |
Scopolia parviflora |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO24850 |
Datura metel |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO25114 |
Linum usitatissimum |
Species |
Linaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO10384 |
Scopolia carniolica |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO18781 |
Hyoscyamus niger |
Species |
Solanaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
Organism ID |
NP ID |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  Biological Activity
Activity Type |
# Activity |
Potency |
12 |
Activity Type |
# Activity |
Individual Protein |
11 |
Protein-Protein Interaction |
1 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT163 |
Individual Protein |
Nuclear factor NF-kappa-B p105 subunit |
Homo sapiens |
Potency |
= |
4466.8 |
nM |
PMID[571081] |
NPT163 |
Individual Protein |
Nuclear factor NF-kappa-B p105 subunit |
Homo sapiens |
Potency |
= |
10000.0 |
nM |
PMID[571082] |
NPT150 |
Individual Protein |
Anthrax lethal factor |
Bacillus anthracis |
Potency |
= |
12589.3 |
nM |
PMID[571083] |
NPT443 |
Individual Protein |
Histone acetyltransferase GCN5 |
Homo sapiens |
Potency |
n.a. |
11220.2 |
nM |
PMID[571084] |
NPT444 |
Individual Protein |
Ubiquitin carboxyl-terminal hydrolase 1 |
Homo sapiens |
Potency |
n.a. |
39810.7 |
nM |
PMID[571084] |
NPT95 |
Individual Protein |
Muscarinic acetylcholine receptor M1 |
Rattus norvegicus |
Potency |
= |
11.2 |
nM |
PMID[571081] |
NPT95 |
Individual Protein |
Muscarinic acetylcholine receptor M1 |
Rattus norvegicus |
Potency |
= |
10.0 |
nM |
PMID[571082] |
NPT95 |
Individual Protein |
Muscarinic acetylcholine receptor M1 |
Rattus norvegicus |
Potency |
= |
4.0 |
nM |
PMID[571081] |
NPT95 |
Individual Protein |
Muscarinic acetylcholine receptor M1 |
Rattus norvegicus |
Potency |
= |
1.1 |
nM |
PMID[571082] |
NPT533 |
Protein-Protein Interaction |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Homo sapiens |
Potency |
n.a. |
35481.3 |
nM |
PMID[571081] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
  Chemically structural similarity: I. Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC169485 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 97 |
0.1-0.2 | 528 |
0.2-0.3 | 1450 |
0.3-0.4 | 5318 |
0.4-0.5 | 20967 |
0.5-0.6 | 12553 |
0.6-0.7 | 1664 |
0.7-0.8 | 99 |
0.8-0.85 | 9 |
0.85-0.9 | 2 |
0.9-0.95 | 4 |
0.95-1 | 6 |
  Chemically structural similarity: II. Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC169485 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 89 |
0.1-0.2 | 329 |
0.2-0.3 | 765 |
0.3-0.4 | 1768 |
0.4-0.5 | 3258 |
0.5-0.6 | 2239 |
0.6-0.7 | 531 |
0.7-0.8 | 116 |
0.8-0.85 | 18 |
0.85-0.9 | 15 |
0.9-0.95 | 12 |
0.95-1 | 10 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD2609 |
Approved |
1.0 |
High Similarity |
NPD4216 |
Approved |
1.0 |
High Similarity |
NPD3131 |
Approved |
1.0 |
High Similarity |
NPD2612 |
Approved |
1.0 |
High Similarity |
NPD2608 |
Approved |
1.0 |
High Similarity |
NPD3132 |
Approved |
1.0 |
High Similarity |
NPD4218 |
Approved |
1.0 |
High Similarity |
NPD2610 |
Approved |
1.0 |
High Similarity |
NPD2611 |
Approved |
1.0 |
High Similarity |
NPD4215 |
Approved |
1.0 |
High Similarity |
NPD4217 |
Approved |
0.9421 |
High Similarity |
NPD2613 |
Approved |
0.9194 |
High Similarity |
NPD3090 |
Approved |
0.9194 |
High Similarity |
NPD3616 |
Approved |
0.9194 |
High Similarity |
NPD4745 |
Approved |
0.9194 |
High Similarity |
NPD2570 |
Approved |
0.9194 |
High Similarity |
NPD3087 |
Approved |
0.9194 |
High Similarity |
NPD3614 |
Approved |
0.9194 |
High Similarity |
NPD3089 |
Approved |
0.9194 |
High Similarity |
NPD3615 |
Approved |
0.9194 |
High Similarity |
NPD4746 |
Phase 3 |
0.9194 |
High Similarity |
NPD2566 |
Approved |
0.9194 |
High Similarity |
NPD2574 |
Discontinued |
0.9194 |
High Similarity |
NPD2571 |
Approved |
0.9194 |
High Similarity |
NPD2572 |
Clinical (unspecified phase) |
0.9194 |
High Similarity |
NPD2573 |
Approved |
0.9194 |
High Similarity |
NPD3088 |
Approved |
0.9048 |
High Similarity |
NPD4684 |
Phase 3 |
0.9048 |
High Similarity |
NPD4685 |
Phase 3 |
0.9048 |
High Similarity |
NPD4686 |
Approved |
0.871 |
High Similarity |
NPD2160 |
Approved |
0.871 |
High Similarity |
NPD2628 |
Approved |
0.871 |
High Similarity |
NPD2626 |
Approved |
0.871 |
High Similarity |
NPD2625 |
Approved |
0.871 |
High Similarity |
NPD2159 |
Approved |
0.871 |
High Similarity |
NPD2627 |
Approved |
0.8403 |
Intermediate Similarity |
NPD2652 |
Approved |
0.8403 |
Intermediate Similarity |
NPD2650 |
Approved |
0.837 |
Intermediate Similarity |
NPD2575 |
Approved |
0.8347 |
Intermediate Similarity |
NPD4574 |
Approved |
0.8347 |
Intermediate Similarity |
NPD4576 |
Approved |
0.8244 |
Intermediate Similarity |
NPD6310 |
Approved |
0.8244 |
Intermediate Similarity |
NPD6311 |
Approved |
0.8244 |
Intermediate Similarity |
NPD6309 |
Approved |
0.822 |
Intermediate Similarity |
NPD1756 |
Approved |
0.822 |
Intermediate Similarity |
NPD1752 |
Approved |
0.8195 |
Intermediate Similarity |
NPD2569 |
Approved |
0.8195 |
Intermediate Similarity |
NPD2567 |
Approved |
0.8167 |
Intermediate Similarity |
NPD2607 |
Approved |
0.813 |
Intermediate Similarity |
NPD2117 |
Pre-registration |
0.813 |
Intermediate Similarity |
NPD2116 |
Approved |
0.813 |
Intermediate Similarity |
NPD2115 |
Approved |
0.8099 |
Intermediate Similarity |
NPD1371 |
Approved |
0.8099 |
Intermediate Similarity |
NPD1373 |
Approved |
0.8099 |
Intermediate Similarity |
NPD1370 |
Approved |
0.8099 |
Intermediate Similarity |
NPD1374 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2994 |
Approved |
0.8 |
Intermediate Similarity |
NPD3032 |
Approved |
0.8 |
Intermediate Similarity |
NPD5204 |
Approved |
0.8 |
Intermediate Similarity |
NPD3661 |
Approved |
0.8 |
Intermediate Similarity |
NPD3031 |
Approved |
0.8 |
Intermediate Similarity |
NPD3664 |
Approved |
0.8 |
Intermediate Similarity |
NPD3663 |
Approved |
0.8 |
Intermediate Similarity |
NPD3648 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3030 |
Approved |
0.8 |
Intermediate Similarity |
NPD3662 |
Phase 3 |
0.7955 |
Intermediate Similarity |
NPD4621 |
Approved |
0.7955 |
Intermediate Similarity |
NPD4619 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5202 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD2946 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD5159 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD5157 |
Phase 1 |
0.7829 |
Intermediate Similarity |
NPD5158 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD5704 |
Approved |
0.7815 |
Intermediate Similarity |
NPD5705 |
Approved |
0.7815 |
Intermediate Similarity |
NPD5706 |
Approved |
0.7803 |
Intermediate Similarity |
NPD5203 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4617 |
Approved |
0.7803 |
Intermediate Similarity |
NPD5201 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4620 |
Approved |
0.7769 |
Intermediate Similarity |
NPD3646 |
Clinical (unspecified phase) |
0.7769 |
Intermediate Similarity |
NPD5667 |
Approved |
0.7742 |
Intermediate Similarity |
NPD4766 |
Approved |
0.7705 |
Intermediate Similarity |
NPD2201 |
Approved |
0.7704 |
Intermediate Similarity |
NPD5121 |
Approved |
0.7704 |
Intermediate Similarity |
NPD5119 |
Approved |
0.7704 |
Intermediate Similarity |
NPD5120 |
Approved |
0.7661 |
Intermediate Similarity |
NPD3598 |
Phase 3 |
0.7656 |
Intermediate Similarity |
NPD5306 |
Approved |
0.7656 |
Intermediate Similarity |
NPD5305 |
Approved |
0.763 |
Intermediate Similarity |
NPD7715 |
Approved |
0.763 |
Intermediate Similarity |
NPD7714 |
Approved |
0.7623 |
Intermediate Similarity |
NPD4233 |
Approved |
0.7623 |
Intermediate Similarity |
NPD4234 |
Approved |
0.76 |
Intermediate Similarity |
NPD1711 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6564 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6563 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6565 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7437 |
Approved |
0.7538 |
Intermediate Similarity |
NPD4806 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7436 |
Approved |
0.7538 |
Intermediate Similarity |
NPD4807 |
Approved |
0.75 |
Intermediate Similarity |
NPD4571 |
Approved |
0.75 |
Intermediate Similarity |
NPD4573 |
Approved |
0.75 |
Intermediate Similarity |
NPD4572 |
Approved |
0.7479 |
Intermediate Similarity |
NPD4719 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD4136 |
Approved |
0.7462 |
Intermediate Similarity |
NPD4106 |
Approved |
0.7462 |
Intermediate Similarity |
NPD4135 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6993 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6994 |
Approved |
0.7422 |
Intermediate Similarity |
NPD6065 |
Approved |
0.7379 |
Intermediate Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6792 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD4738 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD2584 |
Suspended |
0.7343 |
Intermediate Similarity |
NPD7488 |
Clinical (unspecified phase) |
0.7339 |
Intermediate Similarity |
NPD5237 |
Approved |
0.7339 |
Intermediate Similarity |
NPD5239 |
Approved |
0.7339 |
Intermediate Similarity |
NPD5240 |
Approved |
0.7339 |
Intermediate Similarity |
NPD5236 |
Approved |
0.7339 |
Intermediate Similarity |
NPD5235 |
Approved |
0.7338 |
Intermediate Similarity |
NPD8172 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD8173 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4102 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5981 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4105 |
Approved |
0.728 |
Intermediate Similarity |
NPD3644 |
Approved |
0.728 |
Intermediate Similarity |
NPD3643 |
Approved |
0.728 |
Intermediate Similarity |
NPD5927 |
Discontinued |
0.728 |
Intermediate Similarity |
NPD3642 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3681 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3683 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4706 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3680 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3682 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7086 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD6343 |
Approved |
0.7231 |
Intermediate Similarity |
NPD4479 |
Discontinued |
0.7231 |
Intermediate Similarity |
NPD6345 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1654 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD3528 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD4175 |
Approved |
0.7206 |
Intermediate Similarity |
NPD4177 |
Approved |
0.719 |
Intermediate Similarity |
NPD6024 |
Approved |
0.719 |
Intermediate Similarity |
NPD6027 |
Approved |
0.7188 |
Intermediate Similarity |
NPD747 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD7511 |
Approved |
0.7183 |
Intermediate Similarity |
NPD7512 |
Approved |
0.7177 |
Intermediate Similarity |
NPD4095 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD6852 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD5991 |
Approved |
0.7154 |
Intermediate Similarity |
NPD7522 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD5990 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3529 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD4152 |
Approved |
0.7131 |
Intermediate Similarity |
NPD4229 |
Approved |
0.7131 |
Intermediate Similarity |
NPD4231 |
Approved |
0.7119 |
Intermediate Similarity |
NPD1693 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2198 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2199 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3524 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3526 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6073 |
Approved |
0.708 |
Intermediate Similarity |
NPD5759 |
Approved |
0.7077 |
Intermediate Similarity |
NPD5162 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5185 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5184 |
Approved |
0.7071 |
Intermediate Similarity |
NPD8416 |
Discontinued |
0.7071 |
Intermediate Similarity |
NPD5182 |
Approved |
0.7071 |
Intermediate Similarity |
NPD4153 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1090 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1086 |
Approved |
0.7069 |
Intermediate Similarity |
NPD1089 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1989 |
Approved |
0.7049 |
Intermediate Similarity |
NPD854 |
Approved |
0.7049 |
Intermediate Similarity |
NPD855 |
Approved |
0.7049 |
Intermediate Similarity |
NPD4817 |
Approved |
0.7049 |
Intermediate Similarity |
NPD4818 |
Approved |
0.704 |
Intermediate Similarity |
NPD6038 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD4677 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD2066 |
Phase 3 |
0.7015 |
Intermediate Similarity |
NPD5618 |
Discontinued |
0.7008 |
Intermediate Similarity |
NPD4025 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7713 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4655 |
Approved |
0.7 |
Intermediate Similarity |
NPD4657 |
Approved |
0.6986 |
Remote Similarity |
NPD6676 |
Phase 2 |
0.6984 |
Remote Similarity |
NPD4720 |
Approved |
0.6984 |
Remote Similarity |
NPD4717 |
Approved |
0.6984 |
Remote Similarity |
NPD4718 |
Approved |
0.6983 |
Remote Similarity |
NPD800 |
Approved |
0.6978 |
Remote Similarity |
NPD4497 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD6039 |
Approved |
0.6974 |
Remote Similarity |
NPD7749 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD7510 |
Approved |
0.6972 |
Remote Similarity |
NPD5725 |
Approved |
0.697
|
Remote Similarity |
NPD2217 |
Approved |